Total Payments
$189,028
2024 Payments
$39,009
Companies
30
Transactions
455
Medicare Patients
3,048
Medicare Billing
$419,292
Payment Breakdown by Category
Consulting$77,160 (40.8%)
Other$64,140 (33.9%)
Research$27,300 (14.4%)
Travel$10,329 (5.5%)
Food & Beverage$9,785 (5.2%)
Education$241.84 (0.1%)
Gifts$71.52 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $77,160 | 22 | 40.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,140 | 23 | 33.9% |
| Unspecified | $27,300 | 2 | 14.4% |
| Travel and Lodging | $10,329 | 37 | 5.5% |
| Food and Beverage | $9,785 | 364 | 5.2% |
| Education | $241.84 | 6 | 0.1% |
| Gift | $71.52 | 1 | 0.0% |
Payments by Type
General
$161,728
453 transactions
Research
$27,300
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $72,847 | 224 | $0 (2024) |
| Medtronic, Inc. | $46,129 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $33,806 | 61 | $0 (2024) |
| Bausch Health US, LLC | $27,300 | 2 | $0 (2022) |
| PFIZER INC. | $3,893 | 6 | $0 (2024) |
| ALBIREO PHARMA, INC. | $1,971 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $767.00 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $465.81 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $368.39 | 19 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $324.80 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,009 | 111 | Gilead Sciences, Inc. ($25,737) |
| 2023 | $9,053 | 75 | ABBVIE INC. ($8,094) |
| 2022 | $82,679 | 119 | Medtronic, Inc. ($31,204) |
| 2021 | $24,562 | 60 | Medtronic, Inc. ($14,900) |
| 2020 | $555.07 | 26 | AbbVie Inc. ($347.16) |
| 2019 | $28,125 | 47 | AbbVie, Inc. ($27,793) |
| 2018 | $23.97 | 1 | AbbVie, Inc. ($23.97) |
| 2017 | $5,021 | 16 | Gilead Sciences Inc ($4,913) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 12/13/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,736.00 | General |
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: VIROLOGY | ||||||
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $38.86 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $9.00 | General |
| Category: VIROLOGY | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 11/06/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: VIROLOGY | ||||||
| 11/04/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Gastrointestinal AI | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,104.00 | General |
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Alagille syndrome | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $88.19 | General |
| 10/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: VIROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis | Bausch Health US, LLC | $27,300 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 767 | 841 | $302,490 | $98,045 |
| 2022 | 13 | 744 | 797 | $295,136 | $102,175 |
| 2021 | 15 | 757 | 826 | $261,797 | $110,977 |
| 2020 | 15 | 780 | 928 | $315,258 | $108,095 |
Total Patients
3,048
Total Services
3,392
Medicare Billing
$419,292
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 132 | 187 | $56,605 | $26,099 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 133 | 133 | $50,650 | $21,400 | 42.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 98 | 101 | $53,325 | $16,315 | 30.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 53 | $21,630 | $7,434 | 34.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 70 | 70 | $16,922 | $6,606 | 39.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 113 | 123 | $35,580 | $6,535 | 18.4% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 25 | 26 | $13,984 | $5,194 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,278 | $3,229 | 44.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 95 | 98 | $41,002 | $3,171 | 7.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $3,849 | $1,204 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,666 | $858.12 | 51.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 161 | 161 | $62,985 | $26,572 | 42.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 118 | 161 | $50,224 | $22,654 | 45.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 104 | 104 | $55,453 | $17,323 | 31.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 12 | 12 | $14,400 | $8,761 | 60.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 94 | 103 | $30,213 | $6,949 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,341 | $3,375 | 40.5% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $7,959 | $3,164 | 39.8% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $9,828 | $2,996 | 30.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 85 | 85 | $36,024 | $2,967 | 8.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 20 | $8,265 | $2,928 | 35.4% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 58 | 58 | $4,350 | $1,559 | 35.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 14 | $4,537 | $1,505 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,559 | $1,421 | 55.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 175 | 175 | $62,336 | $31,342 | 50.3% |
About Dr. Naveen Gara, M.D
Dr. Naveen Gara, M.D is a Gastroenterology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942406533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Naveen Gara, M.D has received a total of $189,028 in payments from pharmaceutical and medical device companies, with $39,009 received in 2024. These payments were reported across 455 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($77,160).
As a Medicare-enrolled provider, Gara has provided services to 3,048 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $419,292. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location San Diego, CA
- Active Since 06/21/2007
- Last Updated 03/04/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1942406533
Products in Payments
- MAVYRET (Drug) $38,693
- XIFAXAN (Drug) $27,766
- Mavyret (Drug) $24,817
- Epclusa (Drug) $7,068
- XELJANZ (Drug) $3,893
- PILLCAM (Device) $2,298
- Bylvay (Drug) $1,971
- RINVOQ (Biological) $811.07
- LINZESS (Drug) $579.15
- STELARA (Biological) $551.64
- HUMIRA (Biological) $533.31
- ENTYVIO (Biological) $313.48
- OCALIVA (Drug) $295.87
- Vemlidy (Drug) $204.80
- Harvoni (Drug) $174.71
- TREMFYA (Drug) $151.67
- SUTAB (Drug) $143.35
- CREON (Drug) $124.67
- Viekira (Drug) $108.45
- ZEPOSIA (Drug) $102.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in San Diego
William Sandborn, M.d, M.D
Gastroenterology — Payments: $759,525
Gastroenterology $759,525
Dr. David Kunkel, M.d, M.D
Gastroenterology — Payments: $214,394
Gastroenterology $214,394
Dr. Tuan Nguyen, Md, MD
Gastroenterology — Payments: $94,191
Gastroenterology $94,191
Dr. Rena Yadlapati, M.d, M.D
Gastroenterology — Payments: $69,265
Gastroenterology $69,265
Brigid Boland, M.d, M.D
Gastroenterology — Payments: $60,457
Gastroenterology $60,457
Dr. Bernd Schnabl, M.d, M.D
Gastroenterology — Payments: $52,311
Gastroenterology $52,311